Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -0.698\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCOc1ccc(N(CC(=O)Nc2ccc(C)c(Cl)c2)S(C)(=O)=O)cc1
b.) Cc1cc(F)ccc1S(=O)(=O)N1CCCOC1CNC(=O)C(=O)NCc1cccnc1
c.) O=C(CN1C(=O)c2ccccc2S1(=O)=O)NCCSCc1cccc(Cl)c1
d.) COc1ccc(C2CC(c3ccc(Cl)cc3Cl)Nc3nc(N)nn32)cc1OC
e.) CCN(C(=O)CSc1nc(N)cc(N)n1)C1CCS(=O)(=O)C1
Answer: d. COc1ccc(C2CC(c3ccc(Cl)cc3Cl)Nc3nc(N)nn32)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C2CC(c3ccc(Cl)cc3Cl)Nc3nc(N)nn32)cc1OC
COc1ccc(C2CC(c3ccc(Cl)cc3Cl)Nc3nc(N)nn32)cc1OC
5-(2,4-dichlorophenyl)-7-(3,4-dimethoxyphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine